Mitsubishi UFJ Asset Management (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Buy	+4,000	New	+$1.87M	0.92%	37
2025 Q4	–	Sell	-2,200	Closed	-$862K	–	112
2025 Q3	$862K	Buy	+2,200	New	+$919K	0.42%	68
2025 Q2	–	Sell	-1,000	Closed	-$485K	–	118
2025 Q1	$485K	Sell	1,000 -1,500	-60%	-$699K	0.26%	84
2024 Q4	$1.01M	Buy	+2,500	New	+$1.16M	0.44%	58

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s VRTX Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management (UK) opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 4,000 shares worth $1.79M. The stake represents 0.92% of the portfolio and ranks #37 among its holdings. This is a return to the name: Mitsubishi UFJ Asset Management (UK) previously reported a position in VRTX as recently as Q3 2025.

Mitsubishi UFJ Asset Management (UK) first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Mitsubishi UFJ Asset Management (UK) held 4,000 shares of Vertex Pharmaceuticals worth $1.79M as of Q1 2026.
Vertex Pharmaceuticals was a new Mitsubishi UFJ Asset Management (UK) position in Q1 2026.
Vertex Pharmaceuticals made up 0.92% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q1 2026, its #37 holding.
Mitsubishi UFJ Asset Management (UK) first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2026, filed 8 May 2026.